Shares of contract development and manufacturing organization (CDMO) firm Cohance Lifesciences fell as much as 6.2% to ₹906 on Thursday. The decline was due to reported block deals that saw around 3.39 crore shares, or 8.9% of the equity, worth around ₹3,073 crore change hands in early trade.